158 related articles for article (PubMed ID: 19643977)
1. Design, expression and characterization of mutants of fasciculin optimized for interaction with its target, acetylcholinesterase.
Sharabi O; Peleg Y; Mashiach E; Vardy E; Ashani Y; Silman I; Sussman JL; Shifman JM
Protein Eng Des Sel; 2009 Oct; 22(10):641-8. PubMed ID: 19643977
[TBL] [Abstract][Full Text] [Related]
2. Mapping of the binding landscape for a picomolar protein-protein complex through computation and experiment.
Aizner Y; Sharabi O; Shirian J; Dakwar GR; Risman M; Avraham O; Shifman J
Structure; 2014 Apr; 22(4):636-45. PubMed ID: 24613488
[TBL] [Abstract][Full Text] [Related]
3. Structures of recombinant native and E202Q mutant human acetylcholinesterase complexed with the snake-venom toxin fasciculin-II.
Kryger G; Harel M; Giles K; Toker L; Velan B; Lazar A; Kronman C; Barak D; Ariel N; Shafferman A; Silman I; Sussman JL
Acta Crystallogr D Biol Crystallogr; 2000 Nov; 56(Pt 11):1385-94. PubMed ID: 11053835
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of an acetylcholinesterase-fasciculin complex: interaction of a three-fingered toxin from snake venom with its target.
Harel M; Kleywegt GJ; Ravelli RB; Silman I; Sussman JL
Structure; 1995 Dec; 3(12):1355-66. PubMed ID: 8747462
[TBL] [Abstract][Full Text] [Related]
5. Expression and activity of mutants of fasciculin, a peptidic acetylcholinesterase inhibitor from mamba venom.
Marchot P; Prowse CN; Kanter J; Camp S; Ackermann EJ; Radić Z; Bougis PE; Taylor P
J Biol Chem; 1997 Feb; 272(6):3502-10. PubMed ID: 9013597
[TBL] [Abstract][Full Text] [Related]
6. Allosteric control of acetylcholinesterase catalysis by fasciculin.
Radić Z; Quinn DM; Vellom DC; Camp S; Taylor P
J Biol Chem; 1995 Sep; 270(35):20391-9. PubMed ID: 7657613
[TBL] [Abstract][Full Text] [Related]
7. Site of fasciculin interaction with acetylcholinesterase.
Radić Z; Duran R; Vellom DC; Li Y; Cervenansky C; Taylor P
J Biol Chem; 1994 Apr; 269(15):11233-9. PubMed ID: 8157652
[TBL] [Abstract][Full Text] [Related]
8. Conformational transitions in protein-protein association: binding of fasciculin-2 to acetylcholinesterase.
Bui JM; Radic Z; Taylor P; McCammon JA
Biophys J; 2006 May; 90(9):3280-7. PubMed ID: 16473897
[TBL] [Abstract][Full Text] [Related]
9. Theoretical analysis of the structure of the peptide fasciculin and its docking to acetylcholinesterase.
van den Born HK; Radić Z; Marchot P; Taylor P; Tsigelny I
Protein Sci; 1995 Apr; 4(4):703-15. PubMed ID: 7613468
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of acetylcholinesterase inhibition by fasciculin: a 5-ns molecular dynamics simulation.
Tai K; Shen T; Henchman RH; Bourne Y; Marchot P; McCammon JA
J Am Chem Soc; 2002 May; 124(21):6153-61. PubMed ID: 12022850
[TBL] [Abstract][Full Text] [Related]
11. Fasciculin 2 binds to the peripheral site on acetylcholinesterase and inhibits substrate hydrolysis by slowing a step involving proton transfer during enzyme acylation.
Eastman J; Wilson EJ; Cerveñansky C; Rosenberry TL
J Biol Chem; 1995 Aug; 270(34):19694-701. PubMed ID: 7649979
[TBL] [Abstract][Full Text] [Related]
12. Acetylcholinesterase: enhanced fluctuations and alternative routes to the active site in the complex with fasciculin-2.
Bui JM; Tai K; McCammon JA
J Am Chem Soc; 2004 Jun; 126(23):7198-205. PubMed ID: 15186156
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen-bonding interactions in the binding of loop 1 of fasciculin 2 to Torpedo californica acetylcholinesterase: a density functional theory study.
Wang J; Gu J; Leszczynski J
J Phys Chem B; 2005 Jul; 109(28):13761-9. PubMed ID: 16852724
[TBL] [Abstract][Full Text] [Related]
14. Binding of the neurotoxin fasciculin 2 to the acetylcholinesterase peripheral site drastically reduces the association and dissociation rate constants for N-methylacridinium binding to the active site.
Rosenberry TL; Rabl CR; Neumann E
Biochemistry; 1996 Jan; 35(3):685-90. PubMed ID: 8547248
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of mouse acetylcholinesterase by fasciculin: crystal structure of the complex and mutagenesis of fasciculin.
Marchot P; Bourne Y; Prowse CN; Bougis PE; Taylor P
Toxicon; 1998 Nov; 36(11):1613-22. PubMed ID: 9792178
[TBL] [Abstract][Full Text] [Related]
16. Synthetic peptides mimicking the binding site of human acetylcholinesterase for its inhibitor fasciculin 2.
Kafurke U; Erijman A; Aizner Y; Shifman JM; Eichler J
J Pept Sci; 2015 Sep; 21(9):723-30. PubMed ID: 26200472
[TBL] [Abstract][Full Text] [Related]
17. Protein complex formation by acetylcholinesterase and the neurotoxin fasciculin-2 appears to involve an induced-fit mechanism.
Bui JM; McCammon JA
Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15451-6. PubMed ID: 17021015
[TBL] [Abstract][Full Text] [Related]
18. Acetylcholinesterase inhibition by fasciculin: crystal structure of the complex.
Bourne Y; Taylor P; Marchot P
Cell; 1995 Nov; 83(3):503-12. PubMed ID: 8521480
[TBL] [Abstract][Full Text] [Related]
19. [The fasciculin-acetylcholinesterase interaction].
Marchot P
J Soc Biol; 1999; 193(6):505-8. PubMed ID: 10783708
[TBL] [Abstract][Full Text] [Related]
20. Stability of a structural scaffold upon activity transfer: X-ray structure of a three fingers chimeric protein.
Le Du MH; Ricciardi A; Khayati M; Ménez R; Boulain JC; Ménez A; Ducancel F
J Mol Biol; 2000 Mar; 296(4):1017-26. PubMed ID: 10686100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
